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Abstract
The detonation of a radiological dispersion device may result in a situation where individuals 
inhale radioactive materials and require rapid assessment of internal contamination. The feasibility 
of using a 2×2-inch sodium-iodide detector to determine the committed effective dose to an 
individual following acute inhalation of gamma-emitting radionuclides was investigated. 
Experimental configurations of point sources with a polymethyl methacrylate slab phantom were 
used to validate Monte Carlo simulations. The validated detector model was used to simulate the 
responses for four detector positions on six different anthropomorphic phantoms. The nuclides 
examined included 241Am, 60Co, 137Cs, 131I and 192Ir. Biokinetic modelling was employed to 
determine the distributed activity in the body as a function of post-inhalation time. The simulation 
and biokinetic data were used to determine time-dependent count-rate values at optimal detector 
locations on the body for each radionuclide corresponding to a target committed effective dose 
(E50) value of 250 mSv.
INTRODUCTION
The terrorist threat presents numerous challenges for public health professionals. One such 
challenge is the rapid and effective triage of victims of a radiological dispersal device (RDD) 
incident. An RDD incident could leave many people both externally and internally 
contaminated. In such an incident, methods for assessing external contamination are better 
defined, whereas methods for assaying internal contamination for large populations are still 
deficient. In vivo methods are preferable to in vitro methods, as they facilitate the rapid 
screening of triage patients without cumbersome and invasive procedures, which make 
operations arduous in an emergency response scenario. In the former category, whole-body 
counters are the preferred method of assessing internal contamination in the case of gamma-
emitting radionuclides. However, their use in a triage scenario is obviated by their limited 
availability and that they possess a greater sensitivity than required for triage. Availability 
restrictions are also evident for use of medical assay equipment in an emergency triage 
scenario following an RDD incident. Such limitations provide the inherent motivation to 
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investigate whether readily available handheld instruments could be used to assess the 
inhaled contamination levels in a triage environment.
Sodium-iodide [NaI(Tl)] detectors are available in most university and radiation safety 
laboratories in major metropolitan cities. These detectors can serve as spectrometers, are 
robust compared with their semiconductor counterparts and are comparatively inexpensive. 
Such detectors consequently possess the characteristics of a fieldable detector that may be 
useful in a triage scenario in assessing internal contamination with gamma-emitting 
radionuclides.
The detector employed in this study is a Canberra 802 2×2-inch NaI(Tl) scintillation 
detector(1). Although NaI(Tl)-integrated systems are commercially available, such systems 
tend to be automated and costly and lack customisability due to their task-specific design. 
Therefore, this study investigated the use of a standard thallium-doped 2×2-inch NaI(Tl) 
detector, a spectrometer in its bare form, in a field triage scenario to rapidly assess the 
internal contamination of a large number of individuals and prioritise them for further care. 
This approach assumes that each individual is free from any external contamination at the 
time of this screening.
The National Council on Radiation Protection and Measurements (NCRP) Report No. 161 
recommends that 250 mSv be used as the target committed effective dose (E50) value for 
further testing and possible treatment(2). In this study, action-level count rates for the 2×2-
inch NaI detector corresponding to a screening target of 250 mSv committed effective dose 
were calculated for up to 30 d after intake.
MATERIALS AND METHODS
Simulations were employed to determine the detector count rates meeting the 250 mSv 
screening criteria for the distribution of inhaled radionuclides following several days after 
intake. Thus, the 2×2-inch NaI(Tl) detector was modelled using Los Alamos Monte Carlo 
N-Particle Transport Code MCNP-5(3) and validated via a series of benchmark 
measurements to ensure an accurate detector response. The overall procedure employed is 
outlined in the flowchart overview given in Figure 1.
Upon validation of the Monte Carlo detector model, six anthropomorphic phantoms, 
representative of various body types, were modelled with nuclides distributed in major 
organs of the body for each of the five contaminant sources under consideration. After 
simulation, the data were incorporated with the time-dependent biokinetic modelling, from 
which the threshold count-rate values for a 250 mSv committed effective dose were 
calculated. Further specifications and detailed analyses of the benchmarking and simulations 
have been explained in detail by Dewji(4).
Benchmark validation measurements
Slab phantom measurements—The detector models were validated by conducting 
measurements using a polymethyl methacrylate (PMMA) slab phantom. The slab phantom 
consisted of varying thicknesses of PMMA ranging in 6-mm increments from 0 to 90 mm 
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between the source and the detector. The PMMA sheets were followed by a source holder 
constructed of a 6-mm thick PMMA sheet bored with a cylindrical hole to affix the 
radionuclide source. The composition of PMMA (density of 1.19 g cm−3) was 55.6 % 
carbon, 29.6 % oxygen and 14.8 % hydrogen by mass(5). PMMA was chosen for its tissue-
like attenuation behaviour with gamma rays. Thus, varying thicknesses of PMMA were used 
to mimic varying chest-wall thicknesses in humans. For all benchmark measurements, a 
100-mm thickness of Virtual Water™ was placed behind the source holder to simulate the 
gamma-ray backscattering that would result from human tissue. Virtual Water™ (density of 
1.03 g cm−3) is composed of 8.02 % hydrogen, 67.48 % carbon, 2.14 % nitrogen, 19.91 % 
oxygen, 0.14 % chlorine and 2.31 % calcium by mass(6).
The detector model response was simulated for each incremental thickness of PMMA, thus 
replicating the slab phantom benchmark experiments. Consequently, the detector response 
was determined for each of the six nuclides employed in the benchmark measurements to 
ensure that the detector model was validated over a broad range of gamma-ray energies. The 
six sources investigated with the PMMA slab were 241Am, 133Ba, 60Co, 137Cs, 54Mn 
and 22Na, with assay activities given in Table 1. These nuclides were selected for validation 
purposes over a broad range of gamma-ray energies, whereas nuclides specific to RDD 
attacks are elaborated in the subsequent section.
It should be noted that the slab phantom was designed and constructed specifically for 
verifying and validating the MCNP model calculations and should not be considered 
physiological considering that a point source of radiation was emplaced in the phantom.
Detector model—Validation of the detector model resulted from the comparison of the 
experimental data from the slab phantoms with their simulated Monte Carlo model 
counterpart. The detector consisted of a standard 2×2-inch∅ NaI(Tl) scintillating crystal. 
The detector was modelled according to the manufacturer’s design specifications(1), where 
the detector assembly consisted of the NaI(Tl) crystal, a photomultiplier tube and an internal 
magnetic/light shield, which are all hermetically sealed in an aluminium housing.
The gamma source energies and intensities for the nuclides employed in benchmark 
simulations corresponded to those with an emission intensity of >1 %, and were obtained 
from the National Nuclear Data Center through RadToolbox(7, 8).
A pulse-height tally was performed over the active region of the detector crystal to 
determine the pulse-height spectrum. The integrated counts in each primary photopeak 
region of interest (ROI) in the benchmark measurements were compared with those of the 
respective region in the Monte Carlo simulation. A detector response efficiency (scaling) 
factor was calculated for each nuclide based on the comparison for all PMMA thicknesses. 
Consequently, validation of the computational detector model was essential in reproducing 
an accurate detector response.
Measurements were accumulated as 1024-channel pulse-height spectra for the 2×2-inch 
detector. The MCNP pulse-height spectra were similarly binned and tallied into 1024 
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channels spanning a total energy range of 3.25 MeV. A rendering of the 2×2 slab phantom 
model with the detector using the program, VisEd program(9), is depicted in Figure 2.
For the MCNP pulse-height tally, all photoelectric interactions result in a delta function at 
the photon energy rather than a resolution-broadened photopeak. Thus, the Gaussian energy 
broadening (GEB)(3) function in MCNP was employed to attempt to simulate the detector 
resolution. The fit parameters for the GEB function were obtained from a fit of the full-
width-at-half-maximum (FWHM) data of each of the unattenuated sources counts with the 
detector. The GEB function is given in Equation (1), where FWHM of the photopeak is 
given in MeV, E is the peak energy in MeV and a, b, c are the function fit parameters.
(1)
For the nuclides simulated in MCNP, the fit parameters in the GEB employed for the 2×2-
inch detector were a = −0.007, b = 0.065 and c = −0.179. According to the Canberra 
802-2×2 NaI(Tl) detector specifications(1), the crystal has a peak resolution of 8.5 % for the 
662-keV 137Cs peak, where the detector employed in the benchmark data collection yielded 
a peak resolution of 7.46 %, and the corresponding GEB fit had a resolution of 7.31 % at 
the 137Cs energy.
The ROI(s) over which the counts were integrated for each radionuclide were selected to 
capture the nuclide’s primary photopeak(s), which are summarised in Table 2. In practice, 
the endpoints of the ROIs were manually selected to encompass the photopeak. A sample 
ROI selection for both the experimental and MCNP-simulated peaks for the 662-keV peak 
for 137Cs is shown in Figure 3.
The ROIs for 133Ba and 60Co consisted of the amalgamation of multiple adjacent 
photopeaks, which were merged into a single ROI due to their close proximity to each other, 
thus preserving count rates. The remaining nuclides’ ROIs were singly selected peak 
regions, since these characteristic photopeaks were relatively isolated in energy vis-à-vis 
other emissions and represent high-intensity emissions. In addition, the net peak area was 
determined by subtracting the continuum under the peak of the ROI caused by a 
superimposed continuum(10).
Summation peak events were also taken into consideration when acquiring data using the 
PMMA slab phantoms and simulating the detector responses in MCNP. Summation events 
are purely a property of the incident particle flux, detector size and response and do not 
occur in computational modelling. Thus, for the coincidence events occurring in each 
of 60Co, 137Cs and 22Na, these counts were redistributed back to the primary contributing 
photopeaks to attempt to preserve the number of full-energy gamma rays deposited in the 
detector beyond the ROI.
The results of the slab phantom benchmark measurements, in combination with the 
computational models of the slab phantoms, are given as energy-dependent scaling factors.
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Scaling factors
The scaling factors were determined over all PMMA thicknesses for each detector and 
radionuclide. These scaling factors were the ratios of the simulated MCNP count rates with 
the detector counts in the relevant peak ROIs of the benchmark measurements. This 
consequently validated the detector model for each radionuclide regardless of PMMA 
thickness and source-detector geometry. The average ratio for each radionuclide was used as 
a detector-reading scaling factor applicable to other source-detector geometries.
Two nuclides used in the phantom simulations, 131I and 192Ir, were not included in the 
benchmark experiments. Therefore, their scaling factors were extrapolated via an energy-
dependent linear interpolation based on the benchmark radionuclide scaling factors of 
adjacent energy photopeaks. The scaling factors for the benchmark measurements and those 
subsequently applied to the anthropomorphic phantoms are summarised in Table 2. Results 
were weighted towards the 35.8 mm PMMA value, which corresponds to the anteroposterior 
chest wall thickness of the Medical Internal Radiation Dose (MIRD) reference man (mass 
thickness 4.26 g cm−2)(11), and in order to eliminate pile-up events at smaller thicknesses. In 
addition, the peak efficiencies of the six validation for the 2×2-inch NaI(Tl) detector are 
summarised in Table 2, for an unattenuated source placed in contact with the detector 
surface.
Sources of error contributing to the scaling factor error in Table 2 include a predominant 
3.3 % error in the checked source activity, minor contributions from statistical counting error 
in gross and background counts (~0.1–0.3 %), as well as error from the pulse-height tally 
and continuum subtraction (~0.6–1.1 %)(4). For each nuclide, the ratios of the experimental-
to-simulated values were within statistical uncertainty of each other of 1.5-standard 
deviations.
Upon simulation of the appropriate measurements and obtaining a constant-averaged scaling 
factor from the detector response, the detector model was validated for use with the 
anthropomorphic phantoms.
Anthropomorphic phantom models
The computational phantom models employed were based on the MIRD anthropomorphic 
phantoms(11). The MIRD phantoms are based on the reference male and female body types, 
and are based on the mathematical phantoms, which were coded into MCNP(12) using the 
ICRP Publication 23 recommendations(13). The development of the adipose phantoms was 
an extension of these models(14), and resulted in the creation of three additional adult 
phantoms: adipose male, adipose female and post-menopausal adipose female. These 
phantoms have been modified with the addition of a 2-mm layer of skin tissue, an 
oesophagus and a walled colon(15). An androgynous 10-y-old child phantom was 
constructed using BodyBuilder(16). Thus, a total of six phantoms—five adult (two reference, 
three adipose) and a child phantom—were employed in this simulation.
The adult phantoms can be characterised according to their height, body mass index (BMI) 
and the adipose tissue mass. The BMI is calculated as the ratio of the weight (kg) to the 
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square of the height (m2). The physical characteristics of the six phantoms are summarised 
in Table 3.
The radionuclides included in this study were 241Am, 60Co, 137Cs, 131I and 192Ir. These 
were radio-nuclides of ‘greatest concern’ as identified by the Nuclear Regulatory 
Commission and Department of Energy Working Group on RDDs(17). Each phantom was 
simulated with a unit source of each radionuclide distributed uniformly in each organ, from 
which the detector response was determined for the anthropomorphic phantoms.
The validated MCNP detector model once again employed a pulse-height tally to simulate 
the detector response at various locations on the surface of the anthropomorphic phantoms. 
The detector model was placed at four locations about the phantom: Anterior neck, anterior 
and posterior right upper torso and lateral left thigh. Each of these locations was assessed to 
determine which location would yield an optimal detection count rate. All the four locations 
were employed using the reference male phantom, though the anterior upper-right torso 
position was omitted from the remainder of the phantoms due to adipose/breast tissue 
attenuation at this location with the reference female, adipose male, adipose female and 
post-menopausal adipose female phantoms.
The count rates at the four detector locations were simulated and the optimal count-rate 
location for each of the five radionuclides was chosen for use in triaging. The torso locations 
over the right lung were selected, as the three-lobed right lung is larger than the two-lobed 
left lung. Posterior and anterior locations were selected due to attenuation effects of breast 
tissue and fat. The neck was selected, since 131I is a well-known thyroid-seeker. Finally, the 
thigh location was selected, as it represents a large and fleshy muscular region where body 
tissue seeking nuclides may migrate. In addition, significant bone volume is present in the 
thigh from the femur and lower pelvis, where soluble forms of radionuclides, such as 241Am, 
can be significantly deposited significantly in bone, even following early exposure. A 
VisEd(9) representation of these detector placement locations is displayed in Figure 4.
Biokinetic modelling
Biokinetic modelling was employed to simulate the distribution of radionuclides through the 
body as a function of time. The source organ distribution used to represent inhaled source 
contamination was determined using the Dose and Risk Calculation (DCAL) software(18).
The DCAL software implements the ICRP Publication 66 respiratory biokinetics to 
determine the retention factors for a given radionuclide inhalation class in the body as a 
function of time(19). Dosimetric calculations in DCAL are conducted via three main 
steps(18): first, the calculation of the time-dependent activity for the parent nuclide and its 
progeny present in anatomical (source) regions in the body. Second, for all source and target 
regions, specific effective energy (SEE) values are calculated as a function of these source 
and target regions. In the calculation of SEE, dose rates in the target region are given per unit 
of activity in the source. Finally, based on the first two steps, dose (or dose equivalent) rates 
are calculated. The culmination of these three calculations provides dose coefficients, 
providing the integrated organ dose (or dose equivalent) per unit of activity intake.
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DCAL was used to determine the accumulated amount of radionuclide present in an organ 
after a given time—thus tracking the biological/metabolic and radiological decay effects. 
The activity calculation module is a component in the DCAL package that calculates the 
time-dependent activity in various body compartments for a given parent radionuclide.
For each of the five radionuclides under investigation, DCAL was executed using ICRP 
Publication 72 default inhalation types(20). Each nuclide was specified as inhalation from an 
environmental source (vis-à-vis an occupational source) as the intake pathway. A default of 
1 μm was used as the particle’s activity mean aerodynamic diameter(18). The lung absorption 
type (slow [S], moderate [M], fast [F]) corresponded to the speed with which the particulate 
nuclide is absorbed in the lungs, and corresponded to ICRP Publication 72-recommended 
defaults(18, 20). The default lung absorption type for 137Cs and 131I is fast, whereas 60Co 
and 241Am have a moderate uptake speed. Since a default lung absorption type was not 
specified for 192Ir, a moderate uptake was assumed(21). A summary of the default inhalation 
types and environmental inhalation dose coefficients for an adult and child are given in Table 
4.
The fraction of retention only for the significantly contributing compartments was 
determined for each of the five radionuclides under investigation over a period of 30 d. The 
exathoracic compartments, ET1 (anterior nose) and ET2 (posterior nasal passage, mouth, 
larynx, pharynx), from the ICRP Publication 66 respiratory tract model(19) were subtracted 
from the retained lung fraction calculated in DCAL. This rationale is based on the premise 
that most of the contamination from these passages will be removed prior to screening.
The activity retained in the blood calculated by DCAL was distributed among the body 
organs based on the blood distributions given in ICRP Publication 89(22, 23). The remainder 
of the blood not allocated to specific organs was distributed uniformly in the body tissue.
The DCAL output calculates retention as a function of the biological metabolic processes, as 
well as the nuclide’s half-life. The DCAL results showing fraction retained in the body of 
the inhaled activity for all nuclides are displayed in Figures 5–9.
Folding biokinetic with MCNP data
In the MCNP model of the anthropomorphic phantoms, the source contribution tally 
modifier was employed to determine the source organ contribution for each source particle 
that reaches the detector. Once the MCNP tally data for each source compartment at each 
detector location was folded with the DCAL biokinetic data, the resulting output was given 
in counts per Becquerel (Bq) of intake activity. Applying the dose conversion factors at the 
250 mSv action level yields a final result in count rate (cpm) per 250 mSv intake.
Summing the contributions from each source organ from the MCNP pulse-height tally, in 
conjunction with the biokinetic modelling—which contributes the fractional organ 
contribution as a function of time per Bq of intake—yields a total count rate from detector 
per Bq of intake (cpm Bq−1). Finally, by applying dose conversion coefficients for the 
inhaled activity that would lead to a committed effective dose of 250 mSv, the count rate per 
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250 mSv was obtained (cpm 250 mSv−1). Each detector location was tallied for each 
of 241Am, 60Co, 137Cs, 131I and 192Ir (full results available in Dewji(4)).
Detection count-rate thresholds
Since radioactivity count rates tend to fluctuate statistically, a minimum threshold must be 
established to discern a lower limit of detection with confidence above background levels. 
The decision level (DL) was calculated to determine whether or not a sample was detectable 
above background levels with a pre-established confidence interval(24, 25). This estimate, 
based on background measurements, does not serve as a decision-making mechanism, but 
rather describes the detection capability and sensitivity of the system. Thus, a DL must be 
established to determine the net count rate of a sample above background with a pre-
established confidence interval. This DL takes the form of Equation (2).
(2)
In Equation (2), Rb is the background count rate (cpm), tb is the background acquisition time 
(min) and tg is the sample acquisition time (min). For the background data taken with the 
NaI(Tl) detector during the slab phantom measurements, the DL was calculated based on 
Equation (2), and is summarised for various sample acquisition times in Table 5. However, 
as defined by the specific environmental background data in which the detector is employed, 
a count rate of at least 44.5 cpm (from 241Am ROI data) above background is required for 
the 2×2 detector to justify the presence of true activity within 95 % confidence intervals, 
potentially limiting the detection capabilities of 241Am. This count rate was calculated as a 
function of the background spectrum; thus, the minimum detection limit will vary according 
to the background environment in which the patient is being assessed. In a high 
contamination environment, it is possible that the threshold to detect 241Am is increased, 
making it virtually undetectable. However, it can be reasonably expected that screening for 
internal contamination will not take place in a highly contaminated environment.
For 137Cs, 60Co, 131I and 192Ir, a count time of 1 min easily supersedes the DLs, based on 
the facility background in which validation data were acquired (Table 5). It would appear 
that a longer acquisition time for 241Am should be employed, although the triage count rates 
are still above the DL until 20 d after the intake. It is expected that triage operators would 
acquire their own site-specific background and use the net counts summarised in Tables 6 
and 7 to make triaging decisions. In essence, this is only required for 241Am assay.
RESULTS AND DISCUSSION
The optimal location for detector placement in the event of a minimum uptake of 250 mSv 
committed effective dose is dependent on the nuclide inhaled. Overall, the location yielding 
a sufficient, if not optimal, detectable count rate is the posterior right lung. As will be 
discussed, this was the case for all nuclides, with the exception of 131I, where the neck 
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location had proved optimal or very close to optimal for all phantoms, as 131I is a thyroid-
seeker.
Although body type plays a prominent role in determining detector response and count rate, 
it must also be noted that the contaminant nuclide under consideration also contributes to the 
subsequent detector response by its mode of accumulation in the body. For phantoms with 
the detector optimally located at the posterior right torso position, the child phantom tended 
to yield the highest count rate, due to a thin wall and comparatively less attenuation. In 
addition, the higher count rate in the child phantom is also due to the fact the source organs 
are smaller and more compact than those of the adult phantoms, consequently yielding 
increased detection efficiency.
Conversely, the adipose phantoms tended to yield lower count rates, due to increased 
attenuation by a larger chest wall of breast tissue and fat. The adipose male phantom yielded 
the lowest count rates for all but 137Cs, where the post-menopausal female yielded the most 
conservative count rates. Thus, if a single phantom was to be used for triage assessment, the 
adipose male phantom data would provide the most conservative count rates among all adult 
phantoms. Given that it is often difficult to classify adult body-types in a mass triage 
scenario, the adipose male count-rate data for the detector placed over the posterior right 
lung summarised in Table 6 could be used to triage all adult patients. Note that the post-
menopausal female data for 137Cs are employed in Table 6, as it was more conservative than 
the adipose male in the case of this one nuclide. The count-rate data for the detector placed 
over the posterior right lung for an uptake of 250 mSv in the child phantom are summarised 
in Table 7.
The behaviour of 137Cs shows count rates closely distributed when comparing the adult 
phantoms in Figure 10. The optimal detector location for 137Cs occurs when placed over the 
lung location, even though the source of these counts results from contaminant movement 
through the visceral body tissue, not lung retention (fast absorption type), as seen in Figure 
7. In assessing 137Cs levels in all phantoms, the lateral left thigh location yielded counts on 
the same order of magnitude as the posterior lung data. Consequently, the thigh location 
would as a suitable alternative location to the lung for assay ~1 d following initial 
contamination, once the nuclide has migrated. The thigh represents a large form of muscle 
tissue, and given that 137Cs is a fast-absorbing nuclide targeting the body tissue, it is 
reasonable to conclude that the thigh would be a suitable alternative for detection.
In the cases of 60Co and 192Ir, both nuclides have moderate lung absorption types. As seen in 
Figures 11 and 12, respectively, both 60Co and 192Ir tend to receive most of their counts due 
to contributions from where these nuclides tend to accumulate: the lungs, body tissue and 
visceral organs.
In the case of detecting 131I with the detector, its optimal counting location is when placed 
over the anterior neck, where source counts originate from the thyroid (Figure 8). Yet, the 
child phantom yields the lowest count rate (Figure 13) because 131I is rapidly taken up by 
the thyroid gland and proceeds at a higher metabolic rate in a child. Additionally, 131I has a 
short radiological half-life of 8.04 d(8). The neck was determined to be the optimal location 
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for the detection of 131I, though employing the posterior right torso position would also 
yield sufficient counts for assaying contamination and providing a consistent body location 
for all nuclides for first responders during triage.
For the five contaminant nuclides, the majority of the counts tend to originate from either the 
lungs or body tissue. The two distinctively detectable nuclides with moderate lung 
absorptions, 60Co and 192Ir, have a majority of their counts originating from the lungs. 
Conversely, the nuclides with fast lung absorptions, 131I and 137Cs, have a majority of 
counts originating from the body tissue (with the exception of the thyroid uptake of 131I). 
This is due to the fact that the fast-uptake nuclides more rapidly clear the lungs into the 
body, while the moderate-uptake nuclides linger for longer in the lungs. As previously 
mentioned with 137Cs, even though the lung and neck locations yield optimal count rates, 
this is not due to retention in the lungs, but due to counts from the inhaled contaminant 
having metabolised in the body tissue and emitted gammas over these large areas of tissue.
As noted earlier, summation events are not simulated in MCNP. Thus, the simulated detector 
threshold count rates, notably for 60Co and 137Cs, do not account for subsequent summation 
events that occur beyond the ROI in actual NaI(Tl) detectors. Based on the PMMA data, 
these MCNP phantom data were each fitted empirically to yield a relationship between the 
count rate in the ROI and the fraction of detected counts (including summation events) 
occurring in the ROI. This empirical redistribution accounted for the fact that at high 
incidence count rates, a fraction of these counts will occur in the sum peak. This empirical 
correction was applied to the detector response count-rate thresholds obtained from the 
MCNP phantom models, in order to provide realistic detector responses.
The lowest count rate from all the sampled nuclides originated from 241Am. The easily 
attenuated low-energy gamma rays (59.5 keV) permit only a small fraction of the gamma 
rays to reach the detector, thus resulting in a count rate per 250 mSv intake that is many 
orders of magnitude lower than those of the other nuclides. Most of the committed effective 
dose for 241Am is due to the fact that it is predominantly an alpha emitter.
The count rates for 241Am were detectable above the background threshold for all phantoms, 
but the count rates for the adipose male (Figure 14) closely approach the 95 % statistical 
confidence detection limit calculated in Table 5. Additionally, as seen in Table 4, the intake 
quantities of 241Am, corresponding to the 250 mSv screening criterion in both adults and 
children, are approximately four orders of magnitude lower than those of the other nuclides. 
In the absence of the ability to detect low activities of 241Am, it is quite possible that a 
considerable dose can be delivered by the time the detector can definitively detect an 
adequate count rate above the background detection limit. In order to adequately 
detect 241Am, an assay acquisition time well exceeding 10 min will be required. 
Therefore, 241Am is considered tentatively detectable by the NaI(Tl) detector for inhaled 
contamination (Figure 14), best under low background circumstances with higher 
acquisition times. Urine bioassay, if feasible, will provide a more reliable method of 
screening for 241Am.
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CONCLUSION
For the purpose of triage, the 2×2 Na(Tl) detector is capable of assaying individuals having 
inhaled gamma-emitting radionuclides after an RDD incident. The detector is capable of 
definitively assaying the four of the five nuclides investigated: 60Co, 137Cs, 131I and 192Ir at 
levels corresponding to the 250 mSv screening criterion, with a counting time of 1 min. 
However, 241Am closely approaches minimum detection thresholds and consequently may 
not be detected in situations of short counting times and/or in the presence of elevated 
background levels.
Given the complex nature of the instrument and the calibration required, it is strongly 
recommended that trained personnel with experience using sodium-iodide detectors conduct 
the initial instrument set-up and provide supervision during the screening process. The 
detector itself is not hand-portable and requires the set-up of modules, energy calibrations 
and ROI determination. Therefore, only with the assistance of technical personnel 
experienced in operating sodium-iodide detectors is it feasible to use this instrument 
effectively to triage potentially contaminated people. The method described in this study 
provides an additional tool for triage and prioritisation of people when a large population 
needs rapid screening.
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Figure 1. 
Methodology for determining inhalation contamination triage levels using a 2×2-inch 
NaI(Tl) detector.
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Figure 2. 
VisEd representation of PMMA slab phantom model and NaI(Tl) detector.
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Figure 3. 
Sample ‘ROI’ comparison for 137Cs experimental slab data and MCNP simulation model for 
varying thicknesses of PMMA.
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Figure 4. 
Detector placement locations on anthropomorphic phantom: (A) anterior and posterior right 
upper torso; (B) anterior neck; (C) lateral left thigh.
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Figure 5. 
Retention of 241Am (moderate) in major contributing compartments over a 30-d period.
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Figure 6. 
Retention of 60Co (moderate) in major contributing compartments over a 30-d period.
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Figure 7. 
Retention of 137Cs (fast) in major contributing compartments over a 30-d period.
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Figure 8. 
Retention of 131I (fast) in major contributing compartments over a 30-d period.
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Figure 9. 
Retention of 192Ir (moderate) in major contributing compartments over a 30-d period.
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Figure 10. 
Comparison of count rate per phantom for 137Cs at posterior right lung position.
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Figure 11. 
Comparison of count rate per phantom for 60Co at posterior right lung position.
Dewji et al. Page 23
Radiat Prot Dosimetry. Author manuscript; available in PMC 2017 November 28.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 12. 
Comparison of count rate per phantom for 192Ir at posterior right lung position.
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Figure 13. 
Comparison of count rate per phantom for 131I at anterior neck position.
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Figure 14. 
Comparison of count rate per phantom for 241Am at posterior right lung position.
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Table 1
Activities of sources employed in benchmark validation experiments.
Nuclide Assay date (mm/dd/yy) Initial activity (μCi)a Half-life (y) Activity during slab phantom validation (μCi)
241Am 12/09/05 7.50 432 7.48
133Ba 12/09/05 5.20 10.7 4.50
22Na 12/09/05 5.10 5.27 4.02
137Cs 12/09/05 4.90 30.0 4.70
54Mn 12/09/05 5.00 0.86 1.15
60Co 12/09/05 5.00 2.60 3.09
aSources employed are NIST-traceable with an assay error of 3.3 %.
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Table 2
Nuclide gamma-ray photopeak energies and scaling factors radionuclide sources.
Nuclide Peak energy (keV) Emission intensitya Peak efficiency (ROI cps dps−1)b Scaling factor (±σ)
241Amc 59.5 0.357 8.50 % 1.00±0.05
133Bad 276.4 0.071 3.43 % 0.96±0.04
302.9 0.184
356.0 0.622
22Na 511.0 1.798 4.40 % 0.92±0.05
1274.5 0.999 1.75 % 0.97±0.05
137Csc 661.7 0.851 6.47 % 0.89±0.04
54Mn 834.8 0.999 4.87 % 0.93±0.02
60Coc,d 1173.2 0.998 2.31 % 0.85±0.03
1332.5 0.999
131Ic,e 364.5 0.817 0.96
192Irc,d,e 295.9 0.287 0.95
308.4 0.300
316.5 0.828
aValues obtained from National Nuclear Data Center(7).
b
Peak efficiency for unattenuated source on detector surface.
c
Employed in anthropomorphic phantom simulations for ‘nuclides of greatest interest’ in RDD scenario.
dCombined ROI for multiple adjacent photopeaks.
e
Interpolated values from neighbouring photopeak scaling factors.
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Table 3
Anthropomorphic phantom physical characteristics.
Phantom Height (cm) Mass (kg) BMI
Reference male 179 73.1 23
Reference female 168 56.5 20
Adipose male 179 93.7 30
Adipose female 168 73.9 26
Post-menopausal adipose female 168 85.9 30
10-y old androgynous child 140 32.7 N/A
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Table 4
ICRP Publication 72 environmental inhalation dose coefficients(20).
Nuclide Default lung absorption type Adult inhalation coefficient (Bq 250 mSv−1 
intake)
Child inhalation coefficient (Bq 250 mSv−1 
intake)
241Am M 5.95×103 6.25×103
60Co M 2.50×107 1.67×107
137Cs F 5.43×107 1.25×108
131I F 3.38×107 1.32×107
192Ir M 4.81×107 3.29×107
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Table 5
Minimum detectable count rates for various counting times for 2×2-NaI(Tl) detector.
Nuclide Background count rate in ROI (cpm) DL (above background) for various acquisition times (cpm)
1 min 5 min 10 min
241Am 728.2 44.5 20.1 14.4
60Co 969.1 51.4 23.2 16.6
137Cs 542.8 38.4 17.4 12.5
131I 1784.8 69.7 31.5 22.6
192Ir 3701.5 100.4 45.5 32.5
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